CINP World Congress of Neuropsychopharmacology
May 7-10, 2023
Montreal, Canada
Clinical PosterS
The scientific posters accessible via this website have been developed and financially supported by Sumitomo Pharma America, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc.
Copies of posters obtained through this site are for personal use only and may not be reproduced without written permission from the authors.
EVIDENCE FOR THE THERAPEUTIC POTENTIAL OF TAAR1 AGONIST ULOTARONT IN SCHIZOPHRENIA: REVIEW OF PRECLINICAL AND CLINICAL STUDIES
Kenneth S. Koblan, Seth C. Hopkins, Nina Dedic, Courtney Zeni, Heather Dworak
Download the PDF: CLICK HERE
View interactive iPoster: CLICK HERE